Ipatasertib CAS 1001264-89-6

Product Name: GDC-0068
Synonyms: Ipatasertib;(S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one;(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone Ipatasertib (GDC-0068);GDC-0068 (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone;(2S)-2-(4-Chlorophenyl)-1-{4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]-1-piperazinyl}-3-(isopropylamino)-1-propanone;Ipatasertib (GDC-0068,RG 7440);GDC-0068;GDC-0068(RG7440)
CAS: 1001264-89-6
MF: C24H32ClN5O2
MW: 457.99618
EINECS:
Product Categories: -;Inhibitors;Inhibitor;Akt;mTOR;PI3K;PI3K/Akt/mTOR
Mol File: 1001264-89-6.mol

density 1.254
solubility Soluble in DMSO.

Purity: 98%
Appearance:White or light yellow crystalline powder.
Packing: aluminum foil bag/bottle, 25kg/drum or as your request
Uses: is a highly selective pan-Akt inhibitor targeting Akt1, Akt2, and Akt3 with IC50 of 5 nM, 18 nM, and 8 nM, respectively.